Evidence map›Paper›PMID 37401938›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

[

Liling Peng, Yi Liao, Rui Zhou, Yan Zhong, Han Jiang, Jing Wang, Yu Fu, Le Xue, Xiaohui Zhang, Mingxiang Sun and 8 more

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Liling PengShanghai Universal Medical Imaging Diagnostic Center, Shanghai, China.
Yi LiaoDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Rui ZhouDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Yan ZhongDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Han JiangDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Jing WangDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Yu FuCollege of Information Science & Electronic Engineering, Zhejiang University, Hangzhou, China.
Le XueDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Xiaohui ZhangDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.
Mingxiang SunShanghai Universal Medical Imaging Diagnostic Center, Shanghai, China.
Gang FengShanghai Universal Medical Imaging Diagnostic Center, Shanghai, China.
Zhaoting MengShanghai Universal Medical Imaging Diagnostic Center, Shanghai, China.
Sisi PengShanghai Universal Medical Imaging Diagnostic Center, Shanghai, China.
Xuexin HeDepartment of Oncology, Huashan Hospital, Fudan University, Shanghai, China.
Gaojun TengRadiology Department, Zhongda Hospital Southeast University, Nanjing, Jiangsu, China.
Xin GaoShanghai Universal Medical Imaging Diagnostic Center, Shanghai, China. george.ssmu@163.com.
Hong ZhangDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China. hzhang21@zju.edu.cn.ORCID 0000-0002-4084-5150
Mei TianDepartment of Nuclear Medicine and PET-CT Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, China. tianmei@fudan.edu.cn.
Second Affiliated Hospital of Zhejiang University · CNShanghai Medical Information Center · CNFudan University · CNZhejiang Chinese Medical University · CNZhejiang University · CNZhongda Hospital Southeast University · CN

Funding

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China 81725009
6 · The paper itself

Abstract

purposePET/MRI has become an important medical imaging approach in clinical practice. In this study, we retrospectively investigated the detectability of fluorine-18 (

methodsThis study included a total of 3020 asymptomatic subjects who underwent whole-body [

resultsSixty-one subjects were pathologically diagnosed with cancers, among which 59 were correctly detected by [

conclusions[

trial registrationChiCTR2200060041. Registered 16 May 2022. Public site: https://www.chictr.org.cn/index.html.

Indexed as

Breast NeoplasmsLung NeoplasmsFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMaleNeoplasm StagingPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesSensitivity and SpecificityFluorodeoxyglucose F18RadiopharmaceuticalsEarly detection of cancerGlucose metabolismPositron emission tomography/magnetic resonance imaging (PET/MRI)

Identifiers

PMID37401938
PMCPMC10547651
OpenAlexW4383058794

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.